3 Spam-Free Article(s) Found
Sort:
Like
Filter:
7d
Article Searches
Biogen (BIIB) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/04/24/biogen-biib-q1-2024-earnings-call-transcript/?source=iedfolrf0000001 Apr 24, 2024 - BIIB earnings call for the period ending March 31, 2024.
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX https://www.zacks.com/stock/news/2262685/biotech-stock-roundup-biib-bmy-s-q1-earnings-incy-s-acquisition-updates-from-vrtx?cid=CS-ZC-FT-analyst_blog|earnings_article-2262685 Apr 25, 2024 - Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates https://www.zacks.com/stock/news/2263560/sage-therapeutics-sage-q1-earnings-miss-sales-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2263560 Apr 26, 2024 - Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.

Pages: 1

Page 1